AARON DAVIS: Open Payments
NPI 1417628868 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 25 payments from 15 companies in 2025. Trend: 2023 $219 · 2024 $156 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $114 |
| Amgen Inc. | 3 | $54 |
| PFIZER INC. | 2 | $46 |
| Stryker Corporation | 1 | $34 |
| Lilly USA, LLC | 1 | $28 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: Wegovy, EVENITY, PREVNAR 20, Rybelsus, MAKO, MOUNJARO, ACCRUFER, LEQVIO.
Industry payments across ID — which companies pay providers there.
